Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,806 JPY | +0.21% | +0.39% | +19.30% |
Business Summary
Number of employees: 4,298
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Manufacture and Distribution of Pharmaceutical
100.0
%
| 165,615 | 100.0 % | 208,859 | 100.0 % | +26.11% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
74.5
%
| 126,676 | 76.5 % | 155,538 | 74.5 % | +22.78% |
Overseas
25.5
%
| 38,938 | 23.5 % | 53,321 | 25.5 % | +36.94% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Itsuro Yoshida
PSD | President | 73 | 01/79/01 |
Kenichi Inoue
ADM | Chief Administrative Officer | - | - |
Norikazu Inoue
BRD | Director/Board Member | - | - |
Osamu Uchikawa
BRD | Director/Board Member | - | - |
Masao Tanaka
BRD | Director/Board Member | 69 | 01/09/01 |
Shigehiro Kubo
SEC | Corporate Secretary | - | - |
Takeshi Sugiura
PRN | Corporate Officer/Principal | - | - |
Shinya Kida
AUD | Comptroller/Controller/Auditor | - | - |
Hiroyuki Oe
HRO | Human Resources Officer | - | - |
Kunio Sasaki
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Itsuro Yoshida
PSD | President | 73 | 01/79/01 |
Sadayuki Morino
PRN | Corporate Officer/Principal | 70 | 01/81/01 |
Norikazu Eiki
BRD | Director/Board Member | 76 | 01/15/01 |
Yasushi Naito
SAM | Sales & Marketing | 60 | 01/90/01 |
Masao Tanaka
BRD | Director/Board Member | 69 | 01/09/01 |
Kaori Oishi
BRD | Director/Board Member | 47 | 24/20/24 |
Kenryo Goto
BRD | Director/Board Member | - | 25/21/25 |
Osamu Uchikawa
BRD | Director/Board Member | - | - |
Norikazu Inoue
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 51,516,000 | 24,448,973 ( 47.46 %) | 2,296,786 ( 4.458 %) | 47.46 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
2,296,700 | 4.46% | 44,068,965 $ | |
147,040 | 0.00% | 1,512,711 $ | |
60,500 | 0.39% | 937,011 $ | |
4,200 | 0.00% | 84,530 $ |
Company contact information
Towa Pharmaceutical Co., Ltd.
2-11 Shinbashi-cho
571-8580, Kadoma
+81 6 6900 9100
http://www.towayakuhin.co.jpGroup companies
Name | Category and Sector |
---|---|
Dose Innova SL
| |
Towa Pharma International Holdings SL (Sociedad Unipersonal)
|
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.30% | 874M | |
+33.25% | 699B | |
+26.27% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+15.32% | 236B | |
+5.50% | 198B | |
-9.69% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- 4553 Stock
- Company Towa Pharmaceutical Co., Ltd.